Old Web
English
Sign In
Acemap
>
Paper
>
Serum KL-6 as a biomarker to assess risk of worse outcome in patients with SARS-CoV2 infection
Serum KL-6 as a biomarker to assess risk of worse outcome in patients with SARS-CoV2 infection
2021
Sivagurunathan Sutharsan
Marc M. Berger
Jitka Andrä
Lutz-Bernhard Jehn
Christian Taube
Thorsten Brenner
Simone Kattner
Andreas Limmer
Francesco Bonella
Keywords:
Oncology
Biomarker (medicine)
Internal medicine
Medicine
in patient
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]